Recombinant Human KRT13 Protein ，His & Myc

KRT13, or keratin 13, is a type of intermediate filament protein predominantly expressed in the stratified squamous epithelium, particularly in the mucosal surfaces such as the oral cavity and esophagus. This protein plays a crucial role in maintaining cellular integrity and providing mechanical resilience to epithelial tissues. Mutations or dysregulation of KRT13 have been implicated in various pathological conditions, including skin disorders and epithelial cancers, highlighting its significance in both health and disease. Recent studies have focused on the recombinant production of KRT13 to facilitate in-depth functional analyses and explore its potential roles in cell biology and tissue engineering. By utilizing recombinant DNA technology, researchers can generate large quantities of KRT13 protein, which allows for advanced studies into its structural properties, interactions with other cellular components, and its role in epithelial cell differentiation and development. This line of research holds promise for understanding the underlying mechanisms of epithelial disorders and developing novel therapeutic strategies targeting KRT13-related pathways. Furthermore, the recombinant KRT13 protein can serve as a valuable tool in the development of biomaterials and regenerative medicine applications, where its properties may be leveraged to enhance tissue repair and regeneration. Overall, the investigation of KRT13 recombinant protein represents a significant advance in the field of molecular biology and biomedical research, providing insights that could lead to innovative treatments for various epithelial conditions.